Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NeuroSense Announces Continuation of Positive Trends in ALS Clinical Study

americanpharmaceuticalreviewDecember 04, 2020

Tag: NeuroSense , TASMC , NST002 , ALSFRS-R

PharmaSources Customer Service